|  |
Illinois Compiled Statutes
Information maintained by the Legislative Reference Bureau Updating the database of the Illinois Compiled Statutes (ILCS) is an ongoing process. Recent laws may not yet be included in the ILCS database, but they are found on this site as Public Acts soon after they become law. For information concerning the relationship between statutes and Public Acts, refer to the Guide. Because the statute database is maintained primarily for legislative drafting purposes, statutory changes are sometimes included in the statute database before they take effect. If the source note at the end of a Section of the statutes includes a Public Act that has not yet taken effect, the version of the law that is currently in effect may have already been removed from the database and you should refer to that Public Act to see the changes made to the current law.
EXECUTIVE BRANCH
(20 ILCS 5160/) Kidney Disease Prevention and Education Task Force Act. 20 ILCS 5160/Art. 5
(20 ILCS 5160/Art. 5 heading)
Article 5. Health Care Affordability Act
(The Health Care Affordability Act
is compiled at 20 ILCS 2230/)(Source: P.A. 101-649, eff. 7-7-20.)
|
20 ILCS 5160/Art. 10
(20 ILCS 5160/Art. 10 heading)
Article 10. Kidney Disease Prevention
and Education Task Force Act(Source: P.A. 101-649, eff. 7-7-20.) |
20 ILCS 5160/10-1 (20 ILCS 5160/10-1) (Section scheduled to be repealed on June 1, 2026) Sec. 10-1. Short title. This Article may be cited as the Kidney Disease Prevention and Education Task Force Act. References in this Article to "this Act" mean this Article.(Source: P.A. 101-649, eff. 7-7-20.) |
20 ILCS 5160/10-5 (20 ILCS 5160/10-5) (Section scheduled to be repealed on June 1, 2026) Sec. 10-5. Findings. The General Assembly finds that: (1) Chronic kidney disease is the 9th-leading cause | | of death in the United States. An estimated 31 million people in the United States have chronic kidney disease and over 1.12 million people in the State of Illinois are living with the disease. Early chronic kidney disease has no signs or symptoms and, without early detection, can progress to kidney failure.
|
| (2) If a person has high blood pressure, heart
| | disease, diabetes, or a family history of kidney failure, the risk of kidney disease is greater. In Illinois, 13% of all adults have diabetes, and 32% have high blood pressure. The prevalence of diabetes, heart disease, and hypertension is higher for African Americans, who develop kidney failure at a rate of nearly 4 to 1 compared to Caucasians, while Hispanics develop kidney failure at a rate of 2 to 1. Almost half of the people waiting for a kidney in Illinois identify as African American, but, in 2017, less than 10% of them received a kidney.
|
| (3) Although dialysis is a life-extending treatment,
| | the best and most cost-effective treatment for kidney failure is a kidney transplant. Currently, the wait in Illinois for a deceased donor kidney is 5-7 years, and 13 people die while waiting every day.
|
| (4) If chronic kidney disease is detected early and
| | managed appropriately, the individual can receive treatment sooner to help protect the kidneys, the deterioration in kidney function can be slowed or even stopped, and the risk of associated cardiovascular complications and other complications can be reduced.
|
| (5) In light of the COVID-19 pandemic and the
| | increased risk of infection to patients with preexisting conditions, it is imperative to provide those with kidney disease with support.
|
| (Source: P.A. 101-649, eff. 7-7-20.)
|
20 ILCS 5160/10-10 (20 ILCS 5160/10-10) (Section scheduled to be repealed on June 1, 2026) Sec. 10-10. Kidney Disease Prevention and Education Task Force. (a) There is hereby established the Kidney Disease Prevention and Education Task Force to work directly with educational institutions to create health education programs to increase awareness of and to examine chronic kidney disease, transplantations, living and deceased kidney donation, and the existing disparity in the rates of those afflicted between Caucasians and minorities. (b) The Task Force shall develop a sustainable plan to raise awareness about early detection, promote health equity, and reduce the burden of kidney disease throughout the State, which shall include an ongoing campaign that includes health education workshops and seminars, relevant research, and preventive screenings and that promotes social media campaigns and TV and radio commercials. (c) Membership of the Task Force shall be as follows: (1) one member of the Senate, appointed by the Senate | | President, who shall serve as Co-Chair;
|
| (2) one member of the House of Representatives,
| | appointed by the Speaker of the House, who shall serve as Co-Chair;
|
| (3) one member of the House of Representatives,
| | appointed by the Minority Leader of the House;
|
| (4) one member of the Senate, appointed by the Senate
| | (5) one member representing the Department of Public
| | Health, appointed by the Governor;
|
| (6) one member representing the Department of
| | Healthcare and Family Services, appointed by the Governor;
|
| (7) one member representing a medical center in a
| | county with a population of more 3 million residents, appointed by the Co-Chairs;
|
| (8) one member representing a physician's association
| | in a county with a population of more than 3 million residents, appointed by the Co-Chairs;
|
| (9) one member representing a not-for-profit organ
| | procurement organization, appointed by the Co-Chairs;
|
| (10) one member representing a national nonprofit
| | research kidney organization in the State of Illinois, appointed by the Co-Chairs;
|
| (11) the Secretary of State or his or her designee;
(12) one member who is a dialysis patient, appointed
| | (13) one member who is a chronic kidney disease
| | patient, appointed by the Co-Chairs;
|
| (14) one member who is a kidney transplant recipient,
| | appointed by the Co-Chairs;
|
| (15) one member who is a representative of a program
| | working to break down barriers to transplant care in the African American community through access to education, resources, and transplant care, appointed by the Co-Chairs; and
|
| (16) one member who is a representative of a
| | nationwide, non-profit organization with membership for dialysis and pre-dialysis patients and their families, appointed by the Co-Chairs.
|
| (d) Members of the Task Force shall serve without compensation.
(e) The Department of Public Health shall provide administrative support to the Task Force.
(f) The Task Force shall submit its final report to the General Assembly on or before December 31, 2023 and, upon the filing of its final report, is dissolved.
(Source: P.A. 101-649, eff. 7-7-20; 102-671, eff. 11-30-21.)
|
20 ILCS 5160/10-15 (20 ILCS 5160/10-15) (Section scheduled to be repealed on June 1, 2026) Sec. 10-15. Repeal. This Act is repealed on June 1, 2026.(Source: P.A. 102-671, eff. 11-30-21; 103-563, eff. 11-17-23.) |
20 ILCS 5160/Art. 90
(20 ILCS 5160/Art. 90 heading)
Article 90. Amendatory Provisions
(Source: P.A. 101-649, eff. 7-7-20.)
|
20 ILCS 5160/90-5
(20 ILCS 5160/90-5)
Sec. 90-5. (Amendatory provisions; text omitted).
(Source: P.A. 101-649, eff. 7-7-20; text omitted.)
|
20 ILCS 5160/90-10
(20 ILCS 5160/90-10)
Sec. 90-10. (Amendatory provisions; text omitted).
(Source: P.A. 101-649, eff. 7-7-20; text omitted.)
|
20 ILCS 5160/90-15
(20 ILCS 5160/90-15) Sec. 90-15. The Illinois Health Information Exchange and Technology Act is amended by repealing Section 15.
(Source: P.A. 101-649, eff. 7-7-20.)
|
20 ILCS 5160/90-20
(20 ILCS 5160/90-20)
Sec. 90-20. (Amendatory provisions; text omitted).
(Source: P.A. 101-649, eff. 7-7-20; text omitted.)
|
20 ILCS 5160/90-25
(20 ILCS 5160/90-25)
Sec. 90-25. (Amendatory provisions; text omitted).
(Source: P.A. 101-649, eff. 7-7-20; text omitted.)
|
20 ILCS 5160/90-30
(20 ILCS 5160/90-30)
Sec. 90-30. (Amendatory provisions; text omitted).
(Source: P.A. 101-649, eff. 7-7-20; text omitted.)
|
20 ILCS 5160/90-35
(20 ILCS 5160/90-35)
Sec. 90-35. (Amendatory provisions; text omitted).
(Source: P.A. 101-649, eff. 7-7-20; text omitted.)
|
20 ILCS 5160/90-40
(20 ILCS 5160/90-40)
Sec. 90-40. (Amendatory provisions; text omitted).
(Source: P.A. 101-649, eff. 7-7-20; text omitted.)
|
20 ILCS 5160/90-45
(20 ILCS 5160/90-45)
Sec. 90-45. (Amendatory provisions; text omitted).
(Source: P.A. 101-649, eff. 7-7-20; text omitted.)
|
20 ILCS 5160/90-50
(20 ILCS 5160/90-50)
Sec. 90-50. (Amendatory provisions; text omitted).
(Source: P.A. 101-649, eff. 7-7-20; text omitted.)
|
20 ILCS 5160/Art. 99
(20 ILCS 5160/Art. 99 heading)
Article 99. Effective Date
(Source: P.A. 101-649, eff. 7-7-20.)
|
20 ILCS 5160/99-99 (20 ILCS 5160/99-99) (Section scheduled to be repealed on June 1, 2026) Sec. 99-99. Effective date. This Act takes effect upon becoming law.(Source: P.A. 101-649, eff. 7-7-20.) |
|
|
|
|
